avVaa World Health Care Products Brings Skin Care Products to U.S. Hispanic Market
Posted on: Thursday, 26 October 2006, 09:00 CDT
LUMBY, British Columbia, Oct. 26 /PRNewswire-FirstCall/ -- avVaa World Health Care Products Inc. (BULLETIN BOARD: AVVW) , a global biotechnology company offering therapeutic, natural skin and health care products, announced today it has received a $42,000 (USD) initial order from the Hispanic Health Institute (HHI) as part of the Houston Pilot Project for the company's therapeutic skin and health care products.
The HHI order is a result of the Company's Houston Pilot Project, a comprehensive marketing and sales initiative to bring avVaa products to the Hispanic community via HHI. Initially, these products will be marketed to and sold in and around Houston, Texas. Both avVaa and HHI expect the Houston Pilot Project to eventually lead to strong franchise opportunities within the Hispanic community in Canada, the United States, Mexico and other international markets.
The Houston Pilot Project is being guided by the HHI. Dr. Mario Zamora heads the organization as its Director and was recently named an Advisor to avVaa's Board of Directors. HHI is an organization with special expertise and contacts within the Hispanic community throughout North America.
Dr. Zamora said, "I've done several studies on numerous patients with avVaa products. Those patients suffering from aggravated symptoms of seborrheic dermatitis, psoriasis and acne reported vast improvement when using avVaa's NEUROSKIN. This success only increases my enthusiasm for introducing the avVaa NEUROSKIN line of skin treatment products through our Houston Pilot Project. Although nearly anyone with similar skin ailments can benefit from avVaa NEUROSKIN, in my experience, these skin conditions are highly prevalent and severely under treated in the Hispanic community."
Dr. Zamora has studied a number of avVaa care products, all of which are steroid-free, to test their effects when used to treat seborrheic dermatitis, psoriasis and acne.
Lorie Campbell-Farley, avVaa EVP Sales and Marketing said, "I have been working with Dr. Zamora for more than a year now. As a licensed physician, Dr. Zamora has conducted several studies using our NEUROSKIN products over the last year. His results demonstrate that with these products, which are FDA-registered and steroid-free, over-the-counter products; there have been promising results shortly after use in all persons affected by these skin ailments."
About avVaa World Health Care Products
avVaa World Health Care Products (BULLETIN BOARD: AVVW) is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including: eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC NEUROSKIN line of skin care products through mass, food and drug channels in the United States and globally.
Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of AVVAA World Health Care Products, Inc. and no assurance can be given that such results will be achieved. Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.
For additional information on avVaa, contact Jack Farley CEO / Chairman, at 1-866-772-8822 or visit: http://www.avvaa.com/ or http://www.otcfn.com/avvw.
Investor Relations: Merle Goertz (West Coast) of avVaa WorldHealth Care Products, 1-604-688-2349; or Rick McCaffrey of OTC Financial Network, 1-781-444-6100 ext. 625.
avVaa World Health Care Products Inc.
CONTACT: Jack Farley, CEO / Chairman, +1-866-772-8822, or InvestorRelations: Merle Goertz (West Coast), +1-604-688-2349, both of avVaaWorldHealth Care Products; or Rick McCaffrey of OTC Financial Network,+1-781-444-6100 ext. 625
Web site: http://www.avvaa.com/
Source: PRNewswire-FirstCall
Related Articles
- Statement On Oral Health Care Within Health Care Reform
- 'Choose Skin Health' Initiative Kicks Off Second Year
- What Will Women Give Up for Skin Health?
- Jacobson Solutions Teams With HOV Services to Create Holistic Solutions for Managed Care and Health Insurance Organizations
- President/CEO of National Hispanic Medical Association Dr. Elena Rios to Address Health Care and Health Disparities Tonight at Republican National Convention
- Neutrogena(R) Partnership For Skin Health Taps Malin Akerman to Educate About Skin Cancer Detection
- Survey Shows That Awarix Patient Care Visibility System Results in Nurse Job Satisfaction, Efficiency and Quality Benefits
- Merck Joins Celebra Health Campaign in Its Hispanic Community Outreach Effort to Educate Latinas on Cervical Cancer and HPV
- From Sick Care to Health Care: The Principal Financial Group Launches a Nationwide Tour to Educate Brokers
- LPGA Tour Pro Angela Jerman Teamed Up With Dermik Laboratories During Melanoma Month to Benefit the Women's Dermatologic Society, Help Educate Americans About Sun Exposure & Skin Health
 |
 |
User Comments (0)
RSS Feeds